RxDoctor Payments Data

Brandon Fordham, PA

Physician Assistant · Saint Pauls, NCNPI 1568971026

Payments from drug & device makers

$1,218in general payments, 2019–2025

Across 66 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$219
  • Novo Nordisk$161
  • AbbVie$132
  • Amgen$114
  • Xeris Pharmaceuticals, Inc.$113
  • Lilly USA, LLC$100
  • plus $378 from 10 others

What the payments were for

  • Food & beverage$1,218100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,218 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$554
Medicare patients
25
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide87$113,116
FarxigaDapagliflozin Propanediol38$37,682
EliquisApixaban45$32,067
RybelsusSemaglutide21$30,853
JanuviaSitagliptin Phosphate43$26,316
LinzessLinaclotide22$25,946
JardianceEmpagliflozin36$25,561
TrulicityDulaglutide15$21,934
MounjaroTirzepatide12$18,458
VascepaIcosapent Ethyl41$13,458
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,336
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,789
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl66$7,449
Dexlansoprazole DrDexlansoprazole48$7,404
TradjentaLinagliptin13$6,413

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$161$143,969108 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$41$50,83273 claims
Lilly USA, LLCTrulicity, Mounjaro$100$40,39327 claims
Boehringer IngelheimJardiance, Tradjenta$29$31,97449 claims
AbbVieLinzess$132$25,94622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Saint Pauls

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →